by Sue Robbins | Jun 21, 2016 | Migraine
Migraine sufferers are a step closer to getting better treatment after scientists linked genes to the onset of the medical condition. A research team, jointly led by a Queensland, Australia researcher, identified 44 independent DNA variants strongly associated with...
by Sue Robbins | Jun 13, 2016 | Headache Drugs
The US Food and Drug Administration (FDA) is looking into the risk for serious burns and potential permanent scarring with the use of the sumatriptan transdermal patch Zecuity. A single-use, battery-powered patch, Zecuity offers relief of migraine headache pain as...
by Sue Robbins | Jun 7, 2016 | Migraine
Migraine is the third most common disorder in the world and ranks 6th among more than 300 diseases when it comes to the burden it represents. “Determining the factors that trigger migraine attacks is an important, albeit difficult, step in managing...
by Sue Robbins | Jun 2, 2016 | Migraine
The following abstract details a study comparing sex and developmental differences in pediatric migraineurs. The authors believe the clinical implications may increase treatment effectiveness… The prevalence of migraine has an exponential trajectory that is...
by Sue Robbins | May 30, 2016 | Migraine
The following points are part of a framework Dr. Robbins is formulating to teach doctors how to choose headache medications for each person. Past medicines History of medication overuse Insomnia Weight Other associated medical: HTN, DM, immune system problems,...
